The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
the Veterans Administration
Grant: 2I01BX001702
the Veterans Administration
Grant: P50 CA097274
the Veterans Administration
Grant: R01 AI162656
the Veterans Administration
Grant: P30CA086862
the Veterans Administration
Grant: T32 AI007260
the Veterans Administration
Grant: T32 HL007344
NIEHS NIH HHS
Grant: P30 ES005605
NIH HHS
Grant: R01AI62656
BLRD VA
Grant: IK6 BX005392
NIGMS NIH HHS
Grant: T32 GM139776
NIH HHS
Grant: P50CA97274
NIAID NIH HHS
Grant: T32 AI007485
National Institutes of Health
Grant: 2P50CA097274-06
Biostatistics and Bioinformatics
National Institutes of Health
Grant: 5T32AI007260-05
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAM
National Institutes of Health
Grant: 5T32HL007344-30
Program in Hematology:&Cell Biology Blood Cells
National Institutes of Health
Grant: 5I01BX001702-07
TRAF3 as a key regulator of B cell survival pathways
National Institutes of Health
Grant: 1P30CA086862-01
Core--Clinical trials support group
National Institutes of Health
Grant: 3R01AI162656-02S1
Regulation of B cell signaling in autoimmunity by TRAF3
FWCI
0.42
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals